• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,909.39 583.15
(1.11%)
Dow Jones
7,503.05 -1.18
(-0.02%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,673.34 20.47
(0.19%)
Forex
USD-INR
94.99 0.39
(0.42%)
EUR-INR
108.21 0.30
(0.28%)
GBP-INR
125.93 0.66
(0.53%)
JPY-INR
0.58 0.00
(0.27%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3622252
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
34.18
117642.47
EPS(TTM)
Face Value()
Div & Yield %
42.61
2
0.89
 

HB Portfolio reports consolidated net loss of Rs 3.44 crore in the March 2026 quarter
May 30,2026
Net Loss of HB Portfolio reported to Rs 3.44 crore in the quarter ended March 2026 as against net loss of Rs 3.06 crore during the previous quarter ended March 2025. Sales rose 173.26% to Rs 11.75 crore in the quarter ended March 2026 as against Rs 4.30 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.27 crore in the year ended March 2026 as against net loss of Rs 0.05 crore during the previous year ended March 2025. Sales declined 3.74% to Rs 26.80 crore in the year ended March 2026 as against Rs 27.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales11.754.30 173 26.8027.84 -4
OPM %-29.62-43.26 -8.779.52 -
PBDT-3.39-1.77 -92 2.572.78 -8
PBT-3.55-2.08 -71 1.841.95 -6
NP-3.44-3.06 -12 0.27-0.05 LP